BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38461567)

  • 1. Evolving survival gains in patients with young-onset colorectal cancer and synchronous resectable liver metastases.
    Maki H; Haddad A; Lendoire M; Newhook TE; Peacock O; Bednarski BK; Konishi T; Vauthey JN; You YN
    Eur J Surg Oncol; 2024 Apr; 50(4):108057. PubMed ID: 38461567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis.
    Reddy SK; Zorzi D; Lum YW; Barbas AS; Pawlik TM; Ribero D; Abdalla EK; Choti MA; Kemp C; Vauthey JN; Morse MA; White RR; Clary BM
    Ann Surg Oncol; 2009 Jul; 16(7):1809-19. PubMed ID: 18979139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous versus staged resection for synchronous colorectal liver metastases: A population-based cohort study.
    Bogach J; Wang J; Griffiths C; Parpia S; Saskin R; Hallet J; Ruo L; Simunovic M; Serrano PE
    Int J Surg; 2020 Feb; 74():68-75. PubMed ID: 31843676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.
    Gagnière J; Dupré A; Gholami SS; Pezet D; Boerner T; Gönen M; Kingham TP; Allen PJ; Balachandran VP; De Matteo RP; Drebin JA; Yaeger R; Kemeny NE; Jarnagin WR; D'Angelica MI
    Ann Surg; 2020 Jan; 271(1):147-154. PubMed ID: 29995686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases.
    Andreou A; Kopetz S; Maru DM; Chen SS; Zimmitti G; Brouquet A; Shindoh J; Curley SA; Garrett C; Overman MJ; Aloia TA; Vauthey JN
    Ann Surg; 2012 Oct; 256(4):642-50. PubMed ID: 22968062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go?
    Ihnát P; Vávra P; Zonča P
    World J Gastroenterol; 2015 Jun; 21(22):7014-21. PubMed ID: 26078580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Resection for Recurrence After Two-Stage Hepatectomy for Colorectal Liver Metastases Is Feasible, Is Safe, and Improves Survival.
    Lillemoe HA; Kawaguchi Y; Passot G; Karagkounis G; Simoneau E; You YN; Mehran RJ; Chun YS; Tzeng CD; Aloia TA; Vauthey JN
    J Gastrointest Surg; 2019 Jan; 23(1):84-92. PubMed ID: 30084064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of perioperative chemotherapy in patients with colorectal cancer undergoing hepatectomy for resectable synchronous liver metastasis.
    Nakanishi M; Kuriu Y; Murayama Y; Konishi H; Komatsu S; Shiozaki A; Ikoma H; Kubota T; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Otsuji E
    Hepatogastroenterology; 2014 Sep; 61(134):1582-7. PubMed ID: 25436346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical outcomes and prognostic factors in patients with synchronous colorectal liver metastases.
    Fontana R; Herman P; Pugliese V; Perini MV; Coelho FF; Cecconello I
    Arq Gastroenterol; 2014; 51(1):4-9. PubMed ID: 24760056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategies and outcome of surgery for synchronous colorectal liver metastases.
    Reding D; Pestalozzi BC; Breitenstein S; Stupp R; Clavien PA; Slankamenac K; Samaras P
    Swiss Med Wkly; 2017; 147():w14486. PubMed ID: 28871569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes following synchronous liver resection, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal liver and peritoneal metastases: A bi-institutional study.
    Flood MP; Waters PS; Kelly ME; Shields C; Conneely J; Ramsay R; Michael M; Loveday B; Warrier SK; Mulsow J; Heriot AG
    Surg Oncol; 2021 Jun; 37():101553. PubMed ID: 33839444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HEMIHEPATECTOMY FOR RESECTABLE HEPATIC METASTASIS FROM COLORECTAL CANCER WITH POOR PROGNOSIS].
    Patyutko YI; Kotelnikov AG; Mamontov KG; Podluzhny DV; Ponomarenko AA
    Vopr Onkol; 2015; 61(3):439-47. PubMed ID: 26242159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF V600E potentially determines "Oncological Resectability" for "Technically Resectable" colorectal liver metastases.
    Kobayashi S; Takahashi S; Nomura S; Kojima M; Kudo M; Sugimoto M; Konishi M; Gotohda N; Taniguchi H; Yoshino T
    Cancer Med; 2021 Oct; 10(20):6998-7011. PubMed ID: 34535965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status.
    Kawaguchi Y; Kopetz S; Tran Cao HS; Panettieri E; De Bellis M; Nishioka Y; Hwang H; Wang X; Tzeng CD; Chun YS; Aloia TA; Hasegawa K; Guglielmi A; Giuliante F; Vauthey JN
    Br J Surg; 2021 Aug; 108(8):968-975. PubMed ID: 33829254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis.
    Tsai MS; Su YH; Ho MC; Liang JT; Chen TP; Lai HS; Lee PH
    Ann Surg Oncol; 2007 Feb; 14(2):786-94. PubMed ID: 17103254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends and Outcomes of Synchronous Resection of Colorectal Metastasis in the Modern Era-Analysis of Targeted Hepatic NSQIP Database.
    Jones TJ; Murphy AE; Tameron A; Hussain LR; Grannan K; Guend H; Dunki-Jacobs EM; Lee DY
    J Surg Res; 2019 Jun; 238():35-40. PubMed ID: 30735964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of synchronous robotic surgery for colorectal cancer with liver metastases.
    Dwyer RH; Scheidt MJ; Marshall JS; Tsoraides SS
    J Robot Surg; 2018 Dec; 12(4):603-606. PubMed ID: 29704203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is hepatectomy justified for patients with RAS mutant colorectal liver metastases? An analysis of 524 patients undergoing curative liver resection.
    Passot G; Denbo JW; Yamashita S; Kopetz SE; Chun YS; Maru D; Overman MJ; Brudvik KW; Conrad C; Aloia TA; Vauthey JN
    Surgery; 2017 Feb; 161(2):332-340. PubMed ID: 27592215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.